Click here for printer-friendly version
- Fourth quarter net income was $1.28 per share, which included net
realized investment gains of $0.01 per share
- Selling, general and administrative expense ratio continued to improve,
declining by 100 basis points from fourth quarter of 2005
- Full year 2006 net income was $4.82 per share, an increase of 22% from
2005
- Operating cash flow was strong in 2006, exceeding $4.0 billion or 1.3
times net income
- Company expects 1.4 million new members and net income of $5.53 per
share in 2007
INDIANAPOLIS, Jan. 24 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE:
WLP) today announced that fourth quarter 2006 net income was $801.1 million,
or $1.28 per share. These results included $0.01 per share in net realized
investment gains. Net income in the fourth quarter of 2005 was $652.0
million, or $1.04 per share, including $0.01 per share in net realized
investment losses.
Full year 2006 net income was $4.82 per share, including $0.04 per share
in tax benefits resulting from a change in state tax apportionment factors
following the WellChoice acquisition. Net income for the full year of 2005
was $3.94 per share. The 2005 results included expenses of $0.10 per share
due to the multi-district settlement agreement and net realized investment
losses of $0.01 per share, partially offset by benefits of $0.04 per share for
the favorable resolution of a tax matter relating to the sale of certain
subsidiaries in the mid-1990s.
"Throughout 2006, we introduced a number of new products and services that
were focused on improving the health of our members, enhancing quality, and
providing more options to meet the diverse needs of consumers across the
country," said Larry C. Glasscock, chairman, president and chief executive
officer of WellPoint, Inc. "We achieved continued strong growth in our
National Accounts business, successfully introduced Medicare Part D products,
with enrollment reaching 1.6 million members by year-end, and won five new
state contracts to manage approximately 500,000 Medicaid managed care lives.
We are well positioned for future growth with an array of innovative products
and services that engage the consumer and promote the delivery of affordable,
quality health care, including 360 degree Health, an innovative integrated
health, well-being, and medical management program, and Lumenos Consumer
Driven Health Plans ("CDHP")."
"Our financial performance for 2006 was very strong, led by earnings per
share growth of 22 percent for the year," said David C. Colby, executive vice
president and chief financial officer of WellPoint, Inc. "We continued to
price our products with discipline and significantly reduce administrative
costs as a percentage of total revenue. Earnings quality was high, as
evidenced by operating cash flow in excess of $4.0 billion, or 130 percent of
net income. We also continued our share buy-back program, repurchasing nearly
$4.6 billion, or 9.2 percent, of our outstanding shares during 2006. We will
continue to deploy our cash flow in a manner that strengthens operations and
enhances shareholder value in 2007, and expect to return excess capital to our
shareholders through our share repurchase program."
COMPARABLE BASIS INFORMATION
On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For
accounting purposes, the transaction was assumed to have closed on December
31, 2005. Accordingly, operations of the former WellChoice, Inc. are included
in reported financial results for the periods ended in 2006. However,
operations of the former WellChoice, Inc. are not included in reported
financial results for the periods ended in 2005.
Unless otherwise indicated, the analysis in this press release compares
reported financial results and does not adjust results for the effects of this
acquisition. In certain areas, we have included "comparable basis" analyses
that we believe provide more meaningful comparisons between periods, due to
the inclusion of operations of the former WellChoice, Inc. in the comparable
historical results. The "comparable basis" information is not calculated in
accordance with U.S. generally accepted accounting principles ("GAAP") and is
not intended to represent or be indicative of the results that WellPoint, Inc.
would have reported had the acquisition been completed as of the beginning of
the periods presented, and should not be taken as representative or indicative
of our future results. The methodologies for calculating the comparable basis
information are either described within the text of the press release, or in
the tables at the end of the press release where such comparable basis
information is reconciled to WellPoint, Inc.'s reported GAAP financial
results.
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.1 million members at December
31, 2006. During the quarter, the Company's ownership of a joint venture in
Puerto Rico changed from a 50 percent ownership of a Medicaid managed care
subsidiary to a smaller percentage ownership in the joint venture's parent
company. Accordingly, the Company will no longer include the 222,000 members
related to this investment in its reported enrollment, but will continue to
receive financial benefits from these members, along with the commercial and
Medicare members of the joint venture's parent company.
Excluding the impact of this 222,000 member accounting adjustment, the
Company's membership increased by 467,000 members, or 1.4 percent, from the
prior year. This increase was driven by the National Accounts business which
added 632,000 members during the year, representing growth of 7.3 percent.
Partially offsetting the strong performance in National Accounts was a decline
of 348,000 members in the Large Group business resulting from the previously-
announced losses of three large groups totaling approximately 444,000 members.
Operating Revenue: Operating revenue was $14.3 billion in the fourth
quarter of 2006, an increase of 28.7 percent from $11.1 billion in the prior
year quarter.
On a comparable basis, fourth quarter 2006 operating revenue increased by
$1.5 billion, or 12.0 percent, versus $12.8 billion in the prior year period.
The increase resulted primarily from disciplined pricing, enrollment in the
Company's Medicare Part D products, the addition of the New York state
prescription drug contract in 2006, and increased reimbursement in the Federal
Employee Program ("FEP").
Benefit Expense Ratio: The benefit expense ratio was 81.1 percent in the
fourth quarter of 2006, a 140 basis point increase compared with 79.7 percent
in the fourth quarter of 2005.
On a comparable basis, the benefit expense ratio increased by 50 basis
points, from 80.6 percent in the fourth quarter of 2005. The ratio increased
from the prior year due to growth in businesses with benefit expense ratios
higher than the Company average, including the New York state prescription
drug contract, FEP business (for which the Company is reimbursed for its costs
plus a fee), Medicare Advantage plans, and State Sponsored programs. The
impact of this shift in business mix was partially offset by other items,
including Medicare Part D performance in the quarter.
Sequentially, the benefit expense ratio decreased by 20 basis points from
81.3 percent in the third quarter of 2006. The decrease was primarily due to
seasonality, as the lower Medicare Part D benefit expense ratio was partially
offset by higher medical claims resulting from more members reaching their
deductibles towards the end of the calendar year. The benefit expense ratio
did not decline as much as expected because the reduction in the Medicare Part
D benefit expense ratio was smaller than expected due to liabilities incurred
as a result of the CMS reconciliation process such as payments owed to state
Medicaid programs offset by low income subsidy payments. Also during the
quarter, the claims experience in FEP did not decline as much as anticipated
and in three states the Company began Medicaid operations more quickly than
expected. Medicaid programs typically experience a benefit expense ratio
higher than the Company average.
Premium and Cost Trends: Trends include Large Group and ISG fully-insured
businesses.
For the rolling 12-month period ended December 31, 2006, the primary
drivers of medical trend were inpatient and outpatient costs. Full year 2006
medical cost trend was less than 8 percent, and the Company expects that full
year 2007 medical cost trend will remain relatively flat at less than 8
percent. The Company continues to price its commercial business so that
premium yield exceeds total cost trend, where total cost trend includes
medical costs and selling, general and administrative ("SG&A") expense.
SG&A Expense Ratio: The SG&A expense ratio was 15.7 percent in the fourth
quarter of 2006, a decrease of 100 basis points from 16.7 percent in the
fourth quarter of 2005. The current quarter included costs for expensing
stock options in accordance with FAS 123R, which added 20 basis points to the
SG&A ratio, and 10 basis points of severance costs associated with the recent
reorganization.
On a comparable basis, the SG&A expense ratio declined by 110 basis
points, compared with 16.8 percent in the fourth quarter of 2005. The ratio
improved significantly year-over-year as the Company continued to control
spending, spread administrative expenses across a growing revenue base, and
realize integration synergies and efficiencies.
The SG&A expense ratio increased by 20 basis points compared with 15.5
percent in the third quarter of 2006. The increase primarily resulted from
expenses relating to 2007 enrollment preparations, including investment in the
Lumenos CDHP nationwide rollout, increased advertising for the Senior business
open enrollment period, and the reorganization-related severance costs.
Operating Cash Flow: For the year ended December 31, 2006, operating cash
flow totaled $4.0 billion, or 1.3 times net income. In the fourth quarter,
operating cash flow totaled $1.4 billion or 1.8 times net income, which
included payment of $209.5 million in previously-expensed settlement costs
relating to the multi-district litigation.
Days in Claims Payable: Days in claims payable as of December 31, 2006,
was 45.2 days, a decrease of 0.4 days from 45.6 days as of September 30, 2006.
This decline was primarily attributed to a reduction in the length of time
between the date of service and claim payment, and the timing of payments in
the pharmacy benefit management ("PBM") operation.
Share Repurchase Program: During the fourth quarter 2006, the Company
repurchased 7.3 million shares of its common stock for $550.2 million. For
the full year of 2006, the Company repurchased 60.7 million shares for nearly
$4.6 billion. As of December 31, 2006, the Company's remaining Board-approved
share repurchase authorization was $949.8 million. The Company intends to
utilize this authorization during early 2007, subject to market conditions.
At December 31, 2006, cash and investments held at the parent company and
available for general corporate use totaled approximately $1.7 billion.
REPORTABLE SEGMENTS
At December 31, 2006, WellPoint, Inc. had three reportable segments:
Health Care, Specialty, and Other. Operating revenue and operating gain are
the key measures used by management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
(In millions) Three Months Ended December 31 Year Ended December 31
2006 2005 Change 2006 2005 Change
Operating Revenue
Health Care $13,766.6 $10,615.6 29.7% $53,860.6 $41,867.0 28.6%
Specialty 928.9 793.8 17.0% 3,566.2 3,066.1 16.3%
Other:
External
Customers 108.5 76.4 42.0% 454.6 333.6 36.3%
Intercompany
Eliminations (484.9) (361.8) (34.0%) (1,806.8) (1,348.3) (34.0%)
Total Other (376.4) (285.4) (31.9%) (1,352.2) (1,014.7) (33.3%)
Total Operating
Revenue 14,319.1 11,124.0 28.7% 56,074.6 43,918.4 27.7%
Operating Gain
(Loss)
Health Care $1,097.9 $878.5 25.0% $4,288.3 $3,418.0 25.5%
Specialty 143.2 132.8 7.8% 523.6 426.4 22.8%
Other (19.4) (20.0) 3.0% (75.0) (111.9) 33.0%
Health Care: Operating gain for the Health Care segment was approximately
$1.1 billion in the fourth quarter of 2006, an increase of 25.0 percent,
compared with $878.5 million in the fourth quarter of 2005.
On a comparable basis, fourth quarter 2006 operating gain increased by
$143.0 million, or 15.0 percent, compared with $954.9 million in the prior
year quarter. Performance in the Health Care segment improved year-over-year
due to disciplined pricing and underwriting, enrollment in the Company's
Medicare Part D products, and continued SG&A expense control. Operating gain
in the fourth quarter of 2006 included costs of $33.4 million for expensing
stock options in accordance with FAS 123R and $15.9 million of net severance
costs related to the recent reorganization.
Specialty: Operating gain for the Specialty segment totaled $143.2 million
in the fourth quarter of 2006, an increase of 7.8 percent compared with $132.8
million in the fourth quarter of 2005 on both a reported and comparable basis.
The increase resulted primarily from higher prescription volume in the
Company's PBM business with the addition of Medicare Part D and better overall
generic mix in the mail-order operation. These increases in operating gain
were partially offset by higher Vision claims expense, as favorable
development in the fourth quarter of 2005 did not recur in the fourth quarter
of 2006, and the sale of the Company's at-risk Workers' Compensation business
at the end of 2005.
OUTLOOK
Full Year 2007:
- The Company continues to expect net income of $5.53 per share.
- Operating revenue is expected to total approximately $61.9 billion.
- The benefit expense ratio is expected to be approximately 81.5 percent.
- The SG&A expense ratio is expected to be approximately 14.6 percent.
- Operating cash flow is now expected to be at least $4.4 billion, or 1.3
times net income.
- Year-end medical enrollment is expected to be approximately 35.5
million members, representing growth for the year of 1.4 million
members, or 4 percent.
First Quarter 2007:
- The Company continues to expect net income of $1.25 per share.
Basis of Presentation
-
Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
- On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc.
Accordingly, operations of the former WellChoice, Inc. are included in
reported financial results for the periods ended in 2006. However,
operations of the former WellChoice, Inc. are not included in reported
financial results for the periods ended in 2005.
- Amounts for 2005 and prior do not include the impact of expensing stock
options in accordance with FAS 123R. The Company's 2006 reported
results and its outlook for 2007, however, do include this impact.
- The Company expects to revise its reportable segments and customer
types in the first quarter of 2007 in accordance with the new
organizational structure, which reflects how management makes business
decisions beginning January 1, 2007.
- Certain prior period amounts have been reclassified to conform to
current period presentation.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Standard Time ("EST") to discuss its fourth quarter earnings results.
The conference call should be accessed at least 15 minutes prior to the start
of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)
An access code is not required for today's conference call. The access
code for the replay is 850122. The replay will be available from 1:45 p.m. EST
today until the end of the day on February 7, 2007. The call will also be
available through a live webcast at www.wellpoint.com under "Investor Info."
A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
www.wellpoint.com.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT
OF 1995
This press release contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)",
"will", "may", "anticipate(s)" and similar expressions are intended to
identify forward-looking statements. These statements include, but are not
limited to, financial projections and estimates and their underlying
assumptions; statements regarding plans, objectives and expectations with
respect to future operations, products and services; and statements regarding
future performance. Such statements are subject to certain risks and
uncertainties, many of which are difficult to predict and generally beyond the
control of WellPoint, that could cause actual results to differ materially
from those expressed in, or implied or projected by, the forward-looking
information and statements. These risks and uncertainties include: those
discussed and identified in public filings with the U.S. Securities and
Exchange Commission ("SEC") made by WellPoint; trends in health care costs and
utilization rates; our ability to secure sufficient premium rate increases;
competitor pricing below market trends of increasing costs; increased
government regulation of health benefits, managed care and pharmacy benefit
management operations; risks and uncertainties regarding the Medicare Part D
Prescription Drug benefits program, including potential uncollectability of
receivables resulting from processing and/or verifying enrollment (including
facilitated enrollment), inadequacy of underwriting assumptions, inability to
receive and process information, uncollectability of premium from members,
increased pharmaceutical costs, and the underlying seasonality of the
business; significant acquisitions or divestitures by major competitors;
introduction and utilization of new prescription drugs and technology; a
downgrade in our financial strength ratings; litigation and investigations
targeted at health benefits companies and our ability to resolve litigation
and investigations within estimates; our ability to contract with providers
consistent with past practice; other potential uses of cash in the future that
present attractive alternatives to share repurchases; our ability to achieve
expected synergies and operating efficiencies in the WellChoice, Inc.
acquisition within the expected time frames or at all, and to successfully
integrate our operations; our ability to meet expectations regarding
repurchases of shares of our common stock; future bio-terrorist activity or
other potential public health epidemics; and general economic downturns.
Readers are cautioned not to place undue reliance on these forward-looking
statements that speak only as of the date hereof. WellPoint does not undertake
any obligation to republish revised forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events. Readers are also urged to carefully review and consider
the various disclosures in WellPoint's various SEC reports, including but not
limited to WellPoint's Annual Report on Form 10-K for the year ended December
31, 2005, and its Quarterly Reports on Form 10-Q for the reporting periods of
2006.
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
Change from
Dec. 31, Dec. 31, Sept. 30, Dec. 31, Sept. 30,
Medical Membership 2006 2005 2006 2005 2006
Customer Type
Large Group 16,014 16,362 15,926 (2.1%) 0.6%
Individual and Small Group 5,654 5,645 5,651 0.2% 0.1%
National Accounts 5,044 4,776 5,144 5.6% (1.9%)
BlueCard 4,279 3,915 4,214 9.3% 1.5%
Total National 9,323 8,691 9,358 7.3% (0.4%)
Senior 1,229 1,224 1,231 0.4% (0.2%)
State Sponsored (1) 1,881 1,934 2,024 (2.7%) (7.1%)
Total 34,101 33,856 34,190 0.7% (0.3%)
Funding Arrangement
Self-Funded (1) 16,745 16,584 16,937 1.0% (1.1%)
Fully-Insured 17,356 17,272 17,253 0.5% 0.6%
Total 34,101 33,856 34,190 0.7% (0.3%)
Regional Membership
East 13,879 13,800 13,776 0.6% 0.7%
Central (1) 10,907 10,970 11,121 (0.6%) (1.9%)
West 9,315 9,086 9,293 2.5% 0.2%
Total 34,101 33,856 34,190 0.7% (0.3%)
Specialty Metrics
PBM Prescription Volume (2) 95,685 91,804 90,308 4.2% 6.0%
Behavioral Health
Membership 16,937 15,669 16,048 8.1% 5.5%
Life and Disability
Membership 5,970 5,826 5,956 2.5% 0.2%
Dental Membership 5,270 5,195 5,193 1.4% 1.5%
Medicare Part D
Membership (3) 1,568 - 1,569 - (0.1%)
Vision Membership 1,536 816 1,255 88.2% 22.4%
(1) During the quarter, the Company's ownership of a joint venture in
Puerto Rico changed from a 50 percent ownership of a Medicaid managed
care subsidiary to a smaller percentage ownership in the joint
venture's parent company. Accordingly, the Company will no longer
include the 222,000 members related to this investment in its reported
enrollment.
(2) Represents quarterly prescription volume at the Company's PBM
operation.
(3) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
Three Months Ended
(In millions, except per share data) December 31
2006 2005 Change
Revenues
Premiums $13,293.9 $10,285.2 29.3%
Administrative fees 880.7 705.4 24.9%
Other revenue 144.5 133.4 8.3%
Total operating revenue 14,319.1 11,124.0 28.7%
Net investment income 225.3 179.9 25.2%
Net realized gains (losses) on
investments 11.1 (11.6) -
Total revenues 14,555.5 11,292.3 28.9%
Expenses
Benefit expense 10,774.9 8,200.3 31.4%
Selling, general and administrative
expense
Selling expense 424.2 376.5 12.7%
General and administrative expense 1,830.1 1,486.4 23.1%
Total selling, general and
administrative expense 2,254.3 1,862.9 21.0%
Cost of drugs 68.2 69.5 (1.9%)
Interest expense 100.0 58.0 72.4%
Amortization of other intangible assets 74.3 60.2 23.4%
Total expenses 13,271.7 10,250.9 29.5%
Income before income taxes 1,283.8 1,041.4 23.3%
Income taxes 482.7 389.4 24.0%
Net income $801.1 $652.0 22.9%
Net income per diluted share $1.28 $1.04 23.1%
Diluted shares 627.0 629.1 (0.3%)
Benefit expense as a percentage of
premiums 81.1% 79.7% 140 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.7% 16.7% (100)bp
Income before income taxes as a
percentage of total revenues 8.8% 9.2% (40)bp
WellPoint, Inc.
Consolidated Statements of Income
Year Ended
December 31
(In millions, except per share data) 2006 2005 Change
(Unaudited)
Revenues
Premiums $51,971.9 $40,680.0 27.8%
Administrative fees 3,509.6 2,719.2 29.1%
Other revenue 593.1 519.2 14.2%
Total operating revenue 56,074.6 43,918.4 27.7%
Net investment income 878.7 633.1 38.8%
Net realized losses on investments (0.3) (10.2) (97.1%)
Total revenues 56,953.0 44,541.3 27.9%
Expenses
Benefit expense 42,218.8 32,625.2 29.4%
Selling, general and administrative
expense
Selling expense 1,654.5 1,474.2 12.2%
General and administrative expense 7,163.2 5,798.5 23.5%
Total selling, general and
administrative expense 8,817.7 7,272.7 21.2%
Cost of drugs 301.2 288.0 4.6%
Interest expense 403.5 226.2 78.4%
Amortization of other intangible
assets 297.4 238.9 24.5%
Total expenses 52,038.6 40,651.0 28.0%
Income before income taxes 4,914.4 3,890.3 26.3%
Income taxes 1,819.5 1,426.5 27.5%
Net income $3,094.9 $2,463.8 25.6%
Net income per diluted share $4.82 $3.94 22.3%
Diluted shares 642.1 625.8 2.6%
Benefit expense as a percentage of
premiums 81.2% 80.2% 100 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.7% 16.6% (90)bp
Income before income taxes as a
percentage of total revenues 8.6% 8.7% (10)bp
WellPoint, Inc.
Consolidated Balance Sheets
December 31, December 31,
(In millions) 2006 2005
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $2,602.1 $2,740.2
Investments available-for-sale, at
fair value 2,449.9 2,182.8
Other invested assets, current 72.8 307.0
Accrued investment income 157.2 156.8
Premiums and self-funded receivables 2,520.2 2,216.4
Other receivables 1,172.7 743.7
Securities lending collateral 904.7 1,389.9
Deferred tax assets, net 642.6 689.0
Other current assets 1,284.5 1,022.7
Total current assets 11,806.7 11,448.5
Long-term investments 15,687.4 15,106.0
Property and equipment, net 988.6 1,078.6
Goodwill 13,383.5 13,469.1
Other intangible assets 9,396.2 9,686.4
Other noncurrent assets 497.4 498.6
Total assets $51,759.8 $51,287.2
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,290.3 $4,853.4
Reserves for future policy benefits 76.3 82.1
Other policyholder liabilities 2,240.6 1,752.3
Total policy liabilities 7,607.2 6,687.8
Unearned income 987.9 1,057.1
Accounts payable and accrued expenses 3,242.2 2,860.4
Income taxes payable 538.2 833.4
Security trades pending payable 124.8 181.8
Securities lending payable 904.7 1,389.9
Current portion of long-term debt 521.0 481.2
Other current liabilities 1,397.4 1,286.8
Total current liabilities 15,323.4 14,778.4
Long-term debt, less current portion 6,493.2 6,324.7
Reserves for future policy benefits,
noncurrent 646.9 679.9
Deferred tax liability, net 3,350.2 3,267.1
Other noncurrent liabilities 1,370.3 1,244.0
Total liabilities 27,184.0 26,294.1
Shareholders' equity
Common stock 6.1 6.6
Additional paid-in capital 19,863.5 20,915.4
Retained earnings 4,656.1 4,173.5
Unearned stock compensation - (82.1)
Accumulated other comprehensive income (loss) 50.1 (20.3)
Total shareholders' equity 24,575.8 24,993.1
Total liabilities and shareholders' equity $51,759.8 $51,287.2
WellPoint, Inc.
Consolidated Statements of Cash Flows
Year Ended December 31
(In millions) 2006 2005
(Unaudited)
Operating activities
Net income $3,094.9 $2,463.8
Adjustments to reconcile net income to
net cash provided by operating activities:
Net realized losses on investments 0.3 10.2
Loss on disposal of assets 1.7 2.7
Deferred income taxes 273.7 (102.6)
Amortization, net of accretion 471.9 437.9
Depreciation 133.0 118.7
Share-based compensation 246.9 81.2
Excess tax benefits from
share-based compensation (136.5) -
Changes in operating assets and liabilities,
net of effect of business combinations:
Receivables, net (649.4) (230.4)
Other invested assets, current 234.9 -
Other assets (362.4) (165.6)
Policy liabilities 874.2 46.3
Unearned income (69.5) (38.2)
Accounts payable and accrued expenses (91.7) 188.6
Other liabilities 134.2 (136.7)
Income taxes (112.0) 459.6
Net cash provided by operating activities 4,044.2 3,135.5
Investing activities
Purchases of fixed maturity securities (11,198.0) (17,457.0)
Proceeds from sales and maturities of
fixed maturity securities 10,351.7 15,735.9
Purchases of equity securities (2,434.5) (4,530.6)
Proceeds from sales of equity securities 2,950.9 4,480.0
Changes in securities lending collateral 485.2 (731.4)
Purchases of subsidiaries, net of
cash acquired (25.4) (2,589.7)
Proceeds from sales of subsidiaries,
net of cash sold - 92.8
Purchases of property and equipment (193.9) (161.8)
Proceeds from sales of property and equipment 6.4 10.2
Other, net (399.7) -
Net cash used in investing activities (457.3) (5,151.6)
Financing activities
Net (repayments of) proceeds from
commercial paper borrowings (306.0) 808.2
Proceeds from long-term borrowings 2,668.2 1,700.0
Repayment of long-term borrowings (2,162.1) (155.1)
Changes in securities lending payable (485.2) 731.4
Changes in bank overdrafts 414.3 121.2
Repurchase and retirement of common stock (4,550.2) (333.4)
Proceeds from exercise of employee stock
options and employee stock purchase plan 559.5 429.3
Proceeds from sale of put options - 1.1
Excess tax benefits from share-based
compensation 136.5 -
Costs related to issuance of common stock - (3.6)
Net cash (used in) provided by
financing activities (3,725.0) 3,299.1
Change in cash and cash equivalents (138.1) 1,283.0
Cash and cash equivalents at
beginning of year 2,740.2 1,457.2
Cash and cash equivalents at end of year $2,602.1 $2,740.2
WellPoint, Inc.
Reconciliation of Medical Claims Payable
Year Ended December 31
(in millions) 2006 2005 2004
(unaudited)
Gross medical claims payable,
beginning of period $4,853.4 $4,134.0 $1,836.0
Ceded medical claims payable,
beginning of period (27.7) (31.9) (8.7)
Net medical claims payable, beginning
of period 4,825.7 4,102.1 1,827.3
Business combinations and purchase
adjustments (6.4) 784.5 2,331.0
Net incurred medical claims:
Current year 42,613.2 32,865.6 15,344.9
Prior years (redundancies) (1) (617.7) (644.9) (171.9)
Total net incurred medical claims 41,995.5 32,220.7 15,173.0
Net payments attributable to:
Current year medical claims 37,486.0 28,997.1 12,453.2
Prior years medical claims 4,089.5 3,284.5 2,776.0
Total net payments 41,575.5 32,281.6 15,229.2
Net medical claims payable, end of
period 5,239.3 4,825.7 4,102.1
Ceded medical claims, end of period 51.0 27.7 31.9
Gross medical claims payable, end of
period $5,290.3 $4,853.4 $4,134.0
Current year medical claims paid as a
percent of current year net
incurred medical claims 88.0% 88.2% 81.2% (2)
Prior year redundancies in the
current period as a percent of
prior year net medical claims payables
less prior year redundancies in the
current period 14.7% 18.7% 10.4%
Prior year redundancies in the
current period as a percent of
prior year net incurred medical claims -
as reported (3) 1.9% 4.2% 1.4%
Prior year redundancies in the
current period as a percent of
prior year net incurred medical
claims - adjusted for acquisitions (3) 1.6% 2.1% 1.4%
(1) Negative amounts reported for net incurred medical claims related to
prior years result from claims being settled for amounts less than
originally estimated.
(2) This ratio is impacted by having only one month of net incurred
medical claims and payments for the former WellPoint Health Networks
Inc. ("WHN") in 2004. If WHN had not been included in 2004, current
year medical claims payments would have been $12,057.7 million,
current year net incurred medical claims would have been $13,835.1
million and the adjusted ratio would have been 87.2%.
(3) For all periods presented, except for the year ended December 31,
2004, the reported ratio of prior year redundancies in the current
period to prior year net incurred medical claims is impacted by
certain acquisitions (the former WellChoice, Inc. in 2005 and WHN in
2004). The Company has provided ratios adjusted for these
acquisitions in order to demonstrate these impacts. Refer to the
table entitled, "Reconciliation of Medical Claims Payable - Adjusted
Ratios" for details regarding the respective calculation
methodologies.
WellPoint, Inc.
Reconciliation of Medical Claims Payable - Adjusted Ratios
(Unaudited)
Note: Below are reconciliations for the adjusted ratios of prior year
redundancies in the current period to prior year net incurred medical
claims that are included in table entitled, "Reconciliation of Medical
Claims Payable."
Ratio for the Year Ended December 31, 2006
This ratio is impacted by having no net incurred medical claims for
the former WellChoice, Inc. ("WC") in 2005.
Net incurred medical claims related to prior years
(redundancies) - year ended December 31, 2006 (As Reported) $617.7
Net incurred medical claims - year ended December 31, $32,865.6
Ratio (As Reported) 1.9%
Net incurred medical claims - year ended December 31, 2005
(Comparable Basis) (1) $37,676.0
Ratio (As Adjusted) 1.6%
(1) Represents comparable benefit expense, assuming WC had been owned
for the entire year ended December 31, 2005.
Ratio for the Year Ended December 31, 2005
This ratio is impacted by having only one month of net incurred medical
claims for the former WellPoint Health Networks Inc. ("WHN") in 2004.
Net incurred medical claims related to prior years
(redundancies) - year ended December 31, 2005 (As Reported) $644.9
Net incurred medical claims - year ended December 31,
2004 (As Reported) $15,344.9
Ratio (As Reported) 4.2%
Net incurred medical claims - year ended December 31, 2004
(Comparable Basis) 2 $30,819.1
Ratio (As Adjusted) 2.1%
(2) Represents comparable benefit expense, assuming WHN had been owned
for the entire year ended December 31, 2004.
WellPoint, Inc.
Selected Financial Data - Comparable Basis Analysis
(Unaudited)
As Reported Comparable Basis (1)
Three Months Three Months
(In millions) Ended December 31 Ended December 31
2006 2005 % Change 2005 $ Change % Change
Revenues
Premiums $13,293.9 $10,285.2 29.3% $11,792.6 $1,501.3 12.7%
Administrative fees 880.7 705.4 24.9% 855.6 25.1 2.9%
Other revenue 144.5 133.4 8.3% 132.5 12.0 9.1%
Total operating
revenue 14,319.1 11,124.0 28.7% 12,780.7 1,538.4 12.0%
Expenses
Benefit expense 10,774.9 8,200.3 31.4% 9,506.2 1,268.7 13.3%
Selling, general and
administrative
expense
Selling expense 424.2 376.5 12.7% 396.2 28.0 7.1%
General and
administrative
expense 1,830.1 1,486.4 23.1% 1,748.7 81.4 4.7%
Total selling,
general and
administrative
expense 2,254.3 1,862.9 21.0% 2,144.9 109.4 5.1%
Cost of drugs 68.2 69.5 (1.9%) 69.5 (1.3) (1.9%)
Benefit expense as a
percentage of
premiums 81.1% 79.7% 140 bp 80.6% 50 bp
Selling, general and
administrative
expense as a
percentage of total
operating revenue 15.7% 16.7% (100)bp 16.8% (110)bp
As Reported Comparable Basis (1)
(In millions) Year Ended December 31 Year Ended December 31
2006 2005 % Change 2005 $ Change % Change
Revenues
Premiums $51,971.9 $40,680.0 27.8% $46,531.1 $5,440.8 11.7%
Administrative fees 3,509.6 2,719.2 29.1% 3,325.0 184.6 5.6%
Other revenue 593.1 519.2 14.2% 518.2 74.9 14.5%
Total operating
revenue 56,074.6 43,918.4 27.7% 50,374.3 5,700.3 11.3%
Expenses
Benefit expense 42,218.8 32,625.2 29.4% 37,676.0 4,542.8 12.1%
Selling, general and
administrative
expense
Selling expense 1,654.5 1,474.2 12.2% 1,549.6 104.9 6.8%
General and
administrative
expense 7,163.2 5,798.5 23.5% 6,770.0 393.2 5.8%
Total selling,
general and
administrative
expense 8,817.7 7,272.7 21.2% 8,319.6 498.1 6.0%
Cost of drugs 301.2 288.0 4.6% 288.0 13.2 4.6%
Benefit expense as a
percentage of
premiums 81.2% 80.2% 100 bp 81.0% 20 bp
Selling, general and
administrative
expense as a
percentage of total
operating revenue 15.7% 16.6% (90)bp 16.5% (80)bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the tables entitled, "Reclassified Consolidated Statements of
Income - Comparable Basis Reconciliation."
WellPoint, Inc.
Reportable Segment Highlights - Comparable Basis Analysis
(Unaudited)
As Reported Comparable Basis (1)
Three Months Three Months
(In millions) Ended December 31 Ended December 31
2006 2005 % Change 2005 $ Change % Change
Operating Revenue
Health Care
Segment $13,766.6 $10,615.6 29.7% $12,232.7 $1,533.9 12.5%
Specialty
Segment 928.9 793.8 17.0% 801.8 127.1 15.9%
Other Segment (376.4) (285.4) (31.9%) (253.8) (122.6) (48.3%)
Total Operating
Revenue 14,319.1 11,124.0 28.7% 12,780.7 1,538.4 12.0%
Operating Gain
(Loss)
Health Care
Segment $1,097.9 $878.5 25.0% $954.9 $143.0 15.0%
Specialty
Segment 143.2 132.8 7.8% 132.8 10.4 7.8%
Other Segment (19.4) (20.0) 3.0% (27.6) 8.2 29.7%
Operating Margin (2)
Health Care
Segment 8.0% 8.3% (30)bp 7.8% 20 bp
Specialty Segment 15.4% 16.7% (130)bp 16.6% (120)bp
As Reported Comparable Basis (1)
(In millions) Year Ended December 31 Year Ended December 31
2006 2005 % Change 2005 $ Change % Change
Operating Revenue
Health Care
Segment $53,860.6 $41,867.0 28.6% $48,159.6 $5,701.0 11.8%
Specialty
Segment 3,566.2 3,066.1 16.3% 3,098.2 468.0 15.1%
Other Segment (1,352.2) (1,014.7) (33.3%) (883.5) (468.7) (53.1%)
Total Operating
Revenue 56,074.6 43,918.4 27.7% 50,374.3 5,700.3 11.3%
Operating Gain
(Loss)
Health Care
Segment $4,288.3 $3,418.0 25.5% $3,789.6 $498.7 13.2%
Specialty
Segment 523.6 426.4 22.8% 426.9 96.7 22.7%
Other Segment (75.0) (111.9) 33.0% (125.8) 50.8 40.4%
Operating Margin (2)
Health Care
Segment 8.0% 8.2% (20)bp 7.9% 10 bp
Specialty Segment 14.7% 13.9% 80 bp 13.8% 90 bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the tables entitled, "Reclassified Reportable Segment Highlights -
Comparable Basis Reconciliation."
(2) Operating margin is calculated as operating gain as a percentage of
operating revenue.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended December 31, 2005
(In millions) WLP (1) Reclassifica- WLP (1)
As Reported tions (2) Reclassified
Revenues
Premiums $10,410.0 $(124.8) $10,285.2
Administrative fees 707.1 (1.7) 705.4
Other revenue (expense) 146.9 (13.5) 133.4
Total operating revenue 11,264.0 (140.0) 11,124.0
Net investment income 179.9 - 179.9
Net realized (losses) gains on
investments (11.6) - (11.6)
Total revenues 11,432.3 (140.0) 11,292.3
Expenses
Benefit expense 8,340.3 (140.0) 8,200.3
Selling, general and administrative
expense
Selling expense 376.5 - 376.5
General and administrative expense 1,486.4 - 1,486.4
Total selling, general and
administrative expense 1,862.9 - 1,862.9
Cost of drugs 69.5 - 69.5
Interest expense 58.0 - 58.0
Amortization of other intangible assets 60.2 - 60.2
Total expenses 10,390.9 (140.0) 10,250.9
Income before income taxes 1,041.4 - 1,041.4
Income taxes 389.4 - 389.4
Net income $652.0 $- $652.0
Benefit expense as a percentage of
premiums 80.1% 79.7%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.5% 16.7%
Three Months Ended December 31, 2005
WellPoint,
WC (1) Reclass- WC (1) Inc.
(In millions) As ifica- Reclass- Comparable
Reported tions (2) ified Basis (3)
Revenues
Premiums $1,480.5 $26.9 $1,507.4 $11,792.6
Administrative fees 139.7 10.5 150.2 855.6
Other revenue (expense) (0.9) - (0.9) 132.5
Total operating revenue 1,619.3 37.4 1,656.7 12,780.7
Net investment income 25.2 - 25.2 205.1
Net realized (losses) gains on
investments 0.6 - 0.6 (11.0)
Total revenues 1,645.1 37.4 1,682.5 12,974.8
Expenses
Benefit expense 1,283.4 22.5 1,305.9 9,506.2
Selling, general and administrative
expense
Selling expense - 19.7 19.7 396.2
General and administrative
expense 267.1 (4.8) 262.3 1,748.7
Total selling, general and
administrative expense 267.1 14.9 282.0 2,144.9
Cost of drugs - - - 69.5
Interest expense - - - 58.0
Amortization of other intangible
assets - - - 60.2
Total expenses 1,550.5 37.4 1,587.9 11,838.8
Income before income taxes 94.6 - 94.6 1,136.0
Income taxes 45.6 - 45.6 435.0
Net income $49.0 $- $49.0 $701.0
Benefit expense as a percentage of
premiums 86.7% 86.6% 80.6%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.5% 17.0% 16.8%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization.
In connection with the acquisition of WellChoice, Inc., the Company
adopted a consistent practice for reporting minimum premium amendments
to fully-insured contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and
the former WellChoice, Inc. This "Comparable Basis" information
contains no intercompany eliminations or pro forma adjustments
resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.
"Comparable Basis" information is presented in order to provide
investors with a more meaningful comparison to the current period, due
to the acquisition of WellChoice, Inc. "Comparable Basis" information
is not calculated in accordance with GAAP and is not intended to
represent or be indicative of the results that WellPoint, Inc. would
have reported, had the acquisition been completed as of January 1,
2005.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Year Ended December 31, 2005
(In millions) WLP (1) Reclassifica- WLP (1)
As Reported tions (2) Reclassified
Revenues
Premiums $41,216.7 $(536.7) $40,680.0
Administrative fees 2,729.9 (10.7) 2,719.2
Other revenue (expense) 566.5 (47.3) 519.2
Total operating revenue 44,513.1 (594.7) 43,918.4
Net investment income 633.1 - 633.1
Net realized (losses) gains on
investments (10.2) - (10.2)
Total revenues 45,136.0 (594.7) 44,541.3
Expenses
Benefit expense 33,219.9 (594.7) 32,625.2
Selling, general and administrative
expense
Selling expense 1,474.2 - 1,474.2
General and administrative expense 5,798.5 - 5,798.5
Total selling, general and
administrative expense 7,272.7 - 7,272.7
Cost of drugs 288.0 - 288.0
Interest expense 226.2 - 226.2
Amortization of other intangible assets 238.9 - 238.9
Total expenses 41,245.7 (594.7) 40,651.0
Income before income taxes 3,890.3 - 3,890.3
Income taxes 1,426.5 - 1,426.5
Net income $2,463.8 $- $2,463.8
Benefit expense as a percentage of
premiums 80.6% 80.2%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.3% 16.6%
Year Ended December 31, 2005
(In millions) WellPoint,
WC (1) Reclass- WC (1) Inc.
As ifica- Reclass- Comparable
Reported tions (2) ified Basis (3)
Revenues
Premiums $5,862.4 $(11.3) $5,851.1 $46,531.1
Administrative fees 561.5 44.3 605.8 3,325.0
Other revenue (expense) (1.0) - (1.0) 518.2
Total operating revenue 6,422.9 33.0 6,455.9 50,374.3
Net investment income 85.6 - 85.6 718.7
Net realized (losses) gains on
investments 4.8 - 4.8 (5.4)
Total revenues 6,513.3 33.0 6,546.3 51,087.6
Expenses
Benefit expense 5,078.4 (27.6) 5,050.8 37,676.0
Selling, general and
administrative expense
Selling expense - 75.4 75.4 1,549.6
General and administrative
expense 986.3 (14.8) 971.5 6,770.0
Total selling, general and
administrative expense 986.3 60.6 1,046.9 8,319.6
Cost of drugs - - - 288.0
Interest expense - - - 226.2
Amortization of other intangible
assets - - - 238.9
Total expenses 6,064.7 33.0 6,097.7 46,748.7
Income before income taxes 448.6 - 448.6 4,338.9
Income taxes 178.4 - 178.4 1,604.9
Net income $270.2 $- $270.2 $2,734.0
Benefit expense as a percentage of
premiums 86.6% 86.3% 81.0%
Selling, general and administrative
expense as a percentage of total
operating revenue 15.4% 16.2% 16.5%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization.
In connection with the acquisition of WellChoice, Inc., the Company
adopted a consistent practice for reporting minimum premium amendments
to fully-insured contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and
the former WellChoice, Inc. This "Comparable Basis" information
contains no intercompany eliminations or pro forma adjustments
resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.
"Comparable Basis" information is presented in order to provide
investors with a more meaningful comparison to the current period, due
to the acquisition of WellChoice, Inc. "Comparable Basis" information
is not calculated in accordance with GAAP and is not intended to
represent or be indicative of the results that WellPoint, Inc. would
have reported, had the acquisition been completed as of January 1,
2005.
WellPoint, Inc.
Reclassified Reportable Segment Highlights - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended December 31, 2005
(In millions) WLP (1) Reclassifica- WLP (1)
As Reported tions (2) Reclassified
Operating Revenue (4)
Health Care $10,782.8 $(167.2) $10,615.6
Specialty 748.7 45.1 793.8
Other (267.5) (17.9) (285.4)
Commercial Managed Care - - -
Other Insurance Products and Services - - -
Total operating revenue 11,264.0 (140.0) 11,124.0
Operating Gain (Loss) (4)
Health Care 896.2 (17.7) 878.5
Specialty 115.1 17.7 132.8
Other (20.0) - (20.0)
Commercial Managed Care - - -
Other Insurance Products and Services - - -
Three Months Ended December 31, 2005
(In millions) WellPoint,
WC (1) Reclass- WC (1) Inc.
As ifica- Reclass- Comparable
Reported tions (2) ified Basis (3)
Operating Revenue (4)
Health Care $- $1,617.1 $1,617.1 $12,232.7
Specialty - 8.0 8.0 801.8
Other - 31.6 31.6 (253.8)
Commercial Managed Care 1,398.9 (1,398.9) - -
Other Insurance Products and
Services 220.4 (220.4) - -
Total operating revenue 1,619.3 37.4 1,656.7 12,780.7
Operating Gain (Loss) (4)
Health Care - 76.4 76.4 954.9
Specialty - - - 132.8
Other - (7.6) (7.6) (27.6)
Commercial Managed Care 95.1 (95.1) - -
Other Insurance Products and
Services (26.3) 26.3 - -
Year Ended December 31, 2005
(In millions)
WLP (1) Reclassifica- WLP (1)
As Reported tions (2) Reclassified
Operating Revenue (4)
Health Care $42,597.5 $(730.5) $41,867.0
Specialty 2,863.1 203.0 3,066.1
Other (947.5) (67.2) (1,014.7)
Commercial Managed Care - - -
Other Insurance Products and Services - - -
Total operating revenue 44,513.1 (594.7) 43,918.4
Operating Gain (Loss) (4)
Health Care 3,459.0 (41.0) 3,418.0
Specialty 388.1 38.3 426.4
Other (114.6) 2.7 (111.9)
Commercial Managed Care - - -
Other Insurance Products and Services - - -
Year Ended December 31, 2005
(In millions WellPoint,
WC (1) Reclass- WC (1) Inc.
As ifica- Reclass- Comparable
Reported tions (2) ified Basis (3)
Operating Revenue (4)
Health Care $- $6,292.6 $6,292.6 $48,159.6
Specialty - 32.1 32.1 3,098.2
Other - 131.2 131.2 (883.5)
Commercial Managed Care 5,530.7 (5,530.7) - -
Other Insurance Products and
Services 892.2 (892.2) - -
Total operating revenue 6,422.9 33.0 6,455.9 50,374.3
Operating Gain (Loss) (4)
Health Care - 371.6 371.6 3,789.6
Specialty - 0.5 0.5 426.9
Other - (13.9) (13.9) (125.8)
Commercial Managed Care 331.5 (331.5) - -
Other Insurance Products and
Services 26.7 (26.7) - -
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization.
In connection with the acquisition of WellChoice, Inc., the Company
adopted a consistent practice for reporting minimum premium amendments
to fully-insured contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and
the former WellChoice, Inc. This "Comparable Basis" information
contains no intercompany eliminations or pro forma adjustments
resulting from WellPoint, Inc.'s acquisition of WellChoice, Inc.
"Comparable Basis" information is presented in order to provide
investors with a more meaningful comparison to the current period, due
to the acquisition of WellChoice, Inc. "Comparable Basis" information
is not calculated in accordance with GAAP and is not intended to
represent or be indicative of the results that WellPoint, Inc. would
have reported, had the acquisition been completed as of January 1,
2005.
(4) Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment. Operating gain is
defined as operating revenue less benefit expense, selling expense,
general and administrative expense, and cost of drugs. Operating gain
is used to analyze profit or loss on a segment basis. Consolidated
operating gain is a non-GAAP measure.
SOURCE WellPoint, Inc.
CONTACT: Investor Relations, Wayne DeVeydt, +1-317-488-6390, or Media,
Jim Kappel, +1-317-488-6400, both of WellPoint, Inc.